Identification of the estrogen product of extraglandular aromatization of plasma androstenedione

C. D. Edman, E. J. Aiman, J. C. Porter, P. C. MacDonald

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

The purpose of these studies was (1) to determine the duration of urine collection needed for complete excretion of radiolabeled metabolites of estrone following the infusion of (3H)-estrone and (14C)-androstenedione; (2) to compare the transfer constant of conversion of plasma androstenedione to plasma estrone measured from the 3H:14C ratio of plasma estrone [ρ{variant}]BU AE1 after four hours of tracer infusion to the [ρ{variant}]BU AE1 computed from the 3H:14C ratio of urinary estrone; and (3) to determine the duration of tracer infusion required to achieve steady-state conditions in the 3H:14C ratio of plasma estrone when (3H)-estrone and (14C)-androstenedione are infused into obese and nonobese women. We found that the 3H:14C ratios of urinary estrone, estradiol, and estriol are very similar when urine collections are complete and obtained for a sufficient time to allow complete excretion of both (3H)-estrone metabolites and (14C)-estrone metabolites. The rate of urinary excretion of the estrone metabolites is slower in obese subjects than in nonobese subjects. Four-hour infusions of (3H)-estrone and (14C)-androstenedione are insufficient to obtain steady-state conditions in the concentrations of plasma (3H)-estrone and plasma (14C)-estrone derived from infused (14C)-androstenedione. The time required to reach steady-state conditions varies directly with body weight. In thin individuals, seven hours of tracer infusion may be sufficient to reach steady-state conditions when (3H)-estrone and (14C)-androstenedione are infused; whereas, 48 hours of infusion may be necessary to achieve these same conditions in morbidly obese individuals. When the time of infusion required to reach an equilibrium between (14C)-estrone derived from infused (14C)-androstenedione and (3H)-estrone in plasma is analyzed as a function of body weight, a highly significant correlation (p < 0.001) is found. From these studies, we conclude that estrone is the near-exclusive estrogen produced by extraglandular aromatization of plasma androstenedione and that extraglandularly formed estrone enters blood unaltered. Thus, little or no irreversible metabolism of estrone occurs in the tissue site(s) of aromatization.

Original languageEnglish (US)
Pages (from-to)439-447
Number of pages9
JournalAmerican Journal of Obstetrics and Gynecology
Volume130
Issue number4
StatePublished - Feb 15 1978

Fingerprint

Androstenedione
Estrone
Estrogens
Urine Specimen Collection
Body Weight
Estriol

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Identification of the estrogen product of extraglandular aromatization of plasma androstenedione. / Edman, C. D.; Aiman, E. J.; Porter, J. C.; MacDonald, P. C.

In: American Journal of Obstetrics and Gynecology, Vol. 130, No. 4, 15.02.1978, p. 439-447.

Research output: Contribution to journalArticle

Edman, C. D. ; Aiman, E. J. ; Porter, J. C. ; MacDonald, P. C. / Identification of the estrogen product of extraglandular aromatization of plasma androstenedione. In: American Journal of Obstetrics and Gynecology. 1978 ; Vol. 130, No. 4. pp. 439-447.
@article{2a807579489d4150a09324a7e7412a08,
title = "Identification of the estrogen product of extraglandular aromatization of plasma androstenedione",
abstract = "The purpose of these studies was (1) to determine the duration of urine collection needed for complete excretion of radiolabeled metabolites of estrone following the infusion of (3H)-estrone and (14C)-androstenedione; (2) to compare the transfer constant of conversion of plasma androstenedione to plasma estrone measured from the 3H:14C ratio of plasma estrone [ρ{variant}]BU AE1 after four hours of tracer infusion to the [ρ{variant}]BU AE1 computed from the 3H:14C ratio of urinary estrone; and (3) to determine the duration of tracer infusion required to achieve steady-state conditions in the 3H:14C ratio of plasma estrone when (3H)-estrone and (14C)-androstenedione are infused into obese and nonobese women. We found that the 3H:14C ratios of urinary estrone, estradiol, and estriol are very similar when urine collections are complete and obtained for a sufficient time to allow complete excretion of both (3H)-estrone metabolites and (14C)-estrone metabolites. The rate of urinary excretion of the estrone metabolites is slower in obese subjects than in nonobese subjects. Four-hour infusions of (3H)-estrone and (14C)-androstenedione are insufficient to obtain steady-state conditions in the concentrations of plasma (3H)-estrone and plasma (14C)-estrone derived from infused (14C)-androstenedione. The time required to reach steady-state conditions varies directly with body weight. In thin individuals, seven hours of tracer infusion may be sufficient to reach steady-state conditions when (3H)-estrone and (14C)-androstenedione are infused; whereas, 48 hours of infusion may be necessary to achieve these same conditions in morbidly obese individuals. When the time of infusion required to reach an equilibrium between (14C)-estrone derived from infused (14C)-androstenedione and (3H)-estrone in plasma is analyzed as a function of body weight, a highly significant correlation (p < 0.001) is found. From these studies, we conclude that estrone is the near-exclusive estrogen produced by extraglandular aromatization of plasma androstenedione and that extraglandularly formed estrone enters blood unaltered. Thus, little or no irreversible metabolism of estrone occurs in the tissue site(s) of aromatization.",
author = "Edman, {C. D.} and Aiman, {E. J.} and Porter, {J. C.} and MacDonald, {P. C.}",
year = "1978",
month = "2",
day = "15",
language = "English (US)",
volume = "130",
pages = "439--447",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Identification of the estrogen product of extraglandular aromatization of plasma androstenedione

AU - Edman, C. D.

AU - Aiman, E. J.

AU - Porter, J. C.

AU - MacDonald, P. C.

PY - 1978/2/15

Y1 - 1978/2/15

N2 - The purpose of these studies was (1) to determine the duration of urine collection needed for complete excretion of radiolabeled metabolites of estrone following the infusion of (3H)-estrone and (14C)-androstenedione; (2) to compare the transfer constant of conversion of plasma androstenedione to plasma estrone measured from the 3H:14C ratio of plasma estrone [ρ{variant}]BU AE1 after four hours of tracer infusion to the [ρ{variant}]BU AE1 computed from the 3H:14C ratio of urinary estrone; and (3) to determine the duration of tracer infusion required to achieve steady-state conditions in the 3H:14C ratio of plasma estrone when (3H)-estrone and (14C)-androstenedione are infused into obese and nonobese women. We found that the 3H:14C ratios of urinary estrone, estradiol, and estriol are very similar when urine collections are complete and obtained for a sufficient time to allow complete excretion of both (3H)-estrone metabolites and (14C)-estrone metabolites. The rate of urinary excretion of the estrone metabolites is slower in obese subjects than in nonobese subjects. Four-hour infusions of (3H)-estrone and (14C)-androstenedione are insufficient to obtain steady-state conditions in the concentrations of plasma (3H)-estrone and plasma (14C)-estrone derived from infused (14C)-androstenedione. The time required to reach steady-state conditions varies directly with body weight. In thin individuals, seven hours of tracer infusion may be sufficient to reach steady-state conditions when (3H)-estrone and (14C)-androstenedione are infused; whereas, 48 hours of infusion may be necessary to achieve these same conditions in morbidly obese individuals. When the time of infusion required to reach an equilibrium between (14C)-estrone derived from infused (14C)-androstenedione and (3H)-estrone in plasma is analyzed as a function of body weight, a highly significant correlation (p < 0.001) is found. From these studies, we conclude that estrone is the near-exclusive estrogen produced by extraglandular aromatization of plasma androstenedione and that extraglandularly formed estrone enters blood unaltered. Thus, little or no irreversible metabolism of estrone occurs in the tissue site(s) of aromatization.

AB - The purpose of these studies was (1) to determine the duration of urine collection needed for complete excretion of radiolabeled metabolites of estrone following the infusion of (3H)-estrone and (14C)-androstenedione; (2) to compare the transfer constant of conversion of plasma androstenedione to plasma estrone measured from the 3H:14C ratio of plasma estrone [ρ{variant}]BU AE1 after four hours of tracer infusion to the [ρ{variant}]BU AE1 computed from the 3H:14C ratio of urinary estrone; and (3) to determine the duration of tracer infusion required to achieve steady-state conditions in the 3H:14C ratio of plasma estrone when (3H)-estrone and (14C)-androstenedione are infused into obese and nonobese women. We found that the 3H:14C ratios of urinary estrone, estradiol, and estriol are very similar when urine collections are complete and obtained for a sufficient time to allow complete excretion of both (3H)-estrone metabolites and (14C)-estrone metabolites. The rate of urinary excretion of the estrone metabolites is slower in obese subjects than in nonobese subjects. Four-hour infusions of (3H)-estrone and (14C)-androstenedione are insufficient to obtain steady-state conditions in the concentrations of plasma (3H)-estrone and plasma (14C)-estrone derived from infused (14C)-androstenedione. The time required to reach steady-state conditions varies directly with body weight. In thin individuals, seven hours of tracer infusion may be sufficient to reach steady-state conditions when (3H)-estrone and (14C)-androstenedione are infused; whereas, 48 hours of infusion may be necessary to achieve these same conditions in morbidly obese individuals. When the time of infusion required to reach an equilibrium between (14C)-estrone derived from infused (14C)-androstenedione and (3H)-estrone in plasma is analyzed as a function of body weight, a highly significant correlation (p < 0.001) is found. From these studies, we conclude that estrone is the near-exclusive estrogen produced by extraglandular aromatization of plasma androstenedione and that extraglandularly formed estrone enters blood unaltered. Thus, little or no irreversible metabolism of estrone occurs in the tissue site(s) of aromatization.

UR - http://www.scopus.com/inward/record.url?scp=0018192336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018192336&partnerID=8YFLogxK

M3 - Article

C2 - 629288

AN - SCOPUS:0018192336

VL - 130

SP - 439

EP - 447

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4

ER -